Genentech Partners In Pain With Xenon
This article was originally published in The Pink Sheet Daily
Executive Summary
As part of its burgeoning efforts in neuroscience, Genentech will discover and develop compounds and companion diagnostics for the treatment of pain, not an area the company historically has played in.